ESC Professional Premium Access

Effect of SLCO1B1 genotypes on statin intolerance and response to statins

Congress Presentation

About the speakers

Mrs Laura Davis

Harefield Hospital, Harefield (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Tina Zubaida Khan

Harefield Hospital, Harefield (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

6 more presentations in this session

Effect on cholesterol remnants and residual lipid risk with PCSK9 inhibitors: the LIPID-REAL Registry

Speaker: Doctor A. Cordero (Elche, ES)


Simulation study on LDL cholesterol target attainment, ASCVD events, and treatment cost of bempedoic acid in a representative German cohort of high- and very-high-CV risk patients

Speaker: Doctor J. Katzmann (Leipzig, DE)


Persistence to long-term PCSK9 inhibitors treatment and its effectiveness in familial hypercholesterolemia: data from the SAFEHEART study

Speaker: Doctor R. Alonso (SANTIAGO, CL)


LDL-C goal achievement and lipid-lowering therapy in patients by atherosclerotic cardiovascular disease subtype: the SANTORINI study

Speaker: Professor K. Ray (London, GB)


Trends in management of cardiovascular risk factors in young adults who go on to develop coronary artery disease

Speaker: Doctor D. Vikulova (Vancouver, CA)


Access the full session

Lipids - Drug therapy 2

Speakers: Mrs L. Davis, Doctor T. Khan, Doctor A. Cordero, Doctor J. Katzmann, Doctor R. Alonso...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb